139 related articles for article (PubMed ID: 32557644)
21. The CRISPR-Cas9 crATIC HeLa transcriptome: Characterization of a novel cellular model of ATIC deficiency and ZMP accumulation.
Mazzarino RC; Baresova V; Zikánová M; Duval N; Wilkinson TG; Patterson D; Vacano GN
Mol Genet Metab Rep; 2020 Dec; 25():100642. PubMed ID: 32939338
[TBL] [Abstract][Full Text] [Related]
22. A novel function for the N-terminal nucleophile hydrolase fold demonstrated by the structure of an archaeal inosine monophosphate cyclohydrolase.
Kang YN; Tran A; White RH; Ealick SE
Biochemistry; 2007 May; 46(17):5050-62. PubMed ID: 17407260
[TBL] [Abstract][Full Text] [Related]
23. Analysis of substrate binding in individual active sites of bifunctional human ATIC.
Witkowska D; Cox HL; Hall TC; Wildsmith GC; Machin DC; Webb ME
Biochim Biophys Acta Proteins Proteom; 2018 Feb; 1866(2):254-263. PubMed ID: 29042184
[TBL] [Abstract][Full Text] [Related]
24. 5'-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells.
Garcia-Gil M; Pesi R; Perna S; Allegrini S; Giannecchini M; Camici M; Tozzi MG
Neuroscience; 2003; 117(4):811-20. PubMed ID: 12654334
[TBL] [Abstract][Full Text] [Related]
25. ATIC inhibits autophagy in hepatocellular cancer through the AKT/FOXO3 pathway and serves as a prognostic signature for modeling patient survival.
Zhang H; Xia P; Liu J; Chen Z; Ma W; Yuan Y
Int J Biol Sci; 2021; 17(15):4442-4458. PubMed ID: 34803509
[No Abstract] [Full Text] [Related]
26. Characterization of two 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase isozymes from Saccharomyces cerevisiae.
Tibbetts AS; Appling DR
J Biol Chem; 2000 Jul; 275(27):20920-7. PubMed ID: 10877846
[TBL] [Abstract][Full Text] [Related]
27. Catalytic mechanism of the cyclohydrolase activity of human aminoimidazole carboxamide ribonucleotide formyltransferase/inosine monophosphate cyclohydrolase.
Vergis JM; Beardsley GP
Biochemistry; 2004 Feb; 43(5):1184-92. PubMed ID: 14756554
[TBL] [Abstract][Full Text] [Related]
28. Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis.
Ma Z; Cools J; Marynen P; Cui X; Siebert R; Gesk S; Schlegelberger B; Peeters B; De Wolf-Peeters C; Wlodarska I; Morris SW
Blood; 2000 Mar; 95(6):2144-9. PubMed ID: 10706887
[TBL] [Abstract][Full Text] [Related]
29. Relationship between the catalytic sites of human bifunctional IMP synthase.
Szabados E; Christopherson RI
Int J Biochem Cell Biol; 1998 Aug; 30(8):933-42. PubMed ID: 9744084
[TBL] [Abstract][Full Text] [Related]
30. Infection of soybean and pea nodules by Rhizobium spp. purine auxotrophs in the presence of 5-aminoimidazole-4-carboxamide riboside.
Newman JD; Diebold RJ; Schultz BW; Noel KD
J Bacteriol; 1994 Jun; 176(11):3286-94. PubMed ID: 8195084
[TBL] [Abstract][Full Text] [Related]
31. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
Colleoni GW; Bridge JA; Garicochea B; Liu J; Filippa DA; Ladanyi M
Am J Pathol; 2000 Mar; 156(3):781-9. PubMed ID: 10702393
[TBL] [Abstract][Full Text] [Related]
32. Radioassay of bifunctional 5-aminoimidazole-4-carboxamide ribotide transformylase-IMP cyclohydrolase by thin-layer chromatography.
Szabados E; Christopherson RI
Anal Biochem; 1994 Sep; 221(2):401-4. PubMed ID: 7810885
[TBL] [Abstract][Full Text] [Related]
33. 5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis.
Pastore S; Stocco G; Moressa V; Zandonà L; Favretto D; Malusà N; Decorti G; Lepore L; Ventura A
Rheumatol Int; 2015 Apr; 35(4):619-27. PubMed ID: 25240429
[TBL] [Abstract][Full Text] [Related]
34. Modulation of the de novo purine nucleotide pathway as a therapeutic strategy in mitochondrial myopathy.
Kimoloi S
Pharmacol Res; 2018 Dec; 138():37-42. PubMed ID: 30267763
[TBL] [Abstract][Full Text] [Related]
35. 5-Amino-4-Imidazolecarboxamide Ribonucleotide Transformylase/IMP Cyclohydrolase Polymorphisms Affect the Susceptibility to Multiple Myeloma.
Wang Y; Ling Z; Hu Z; Gui Y; Huang C; Yao Y; Li R
Lab Med; 2022 Sep; 53(5):465-474. PubMed ID: 35397004
[TBL] [Abstract][Full Text] [Related]
36. Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.
Lee YH; Bae SC
Rheumatol Int; 2016 Nov; 36(11):1591-1599. PubMed ID: 27379764
[TBL] [Abstract][Full Text] [Related]
37. The kinetic mechanism of the human bifunctional enzyme ATIC (5-amino-4-imidazolecarboxamide ribonucleotide transformylase/inosine 5'-monophosphate cyclohydrolase). A surprising lack of substrate channeling.
Bulock KG; Beardsley GP; Anderson KS
J Biol Chem; 2002 Jun; 277(25):22168-74. PubMed ID: 11948179
[TBL] [Abstract][Full Text] [Related]
38. Crystal structures of human bifunctional enzyme aminoimidazole-4-carboxamide ribonucleotide transformylase/IMP cyclohydrolase in complex with potent sulfonyl-containing antifolates.
Cheong CG; Wolan DW; Greasley SE; Horton PA; Beardsley GP; Wilson IA
J Biol Chem; 2004 Apr; 279(17):18034-45. PubMed ID: 14966129
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of ATIC in multiple myeloma tissues based on tissue microarray and gene microarrays.
Li R; Chen G; Dang Y; He R; Liu A; Ma J; Wang C
Int J Lab Hematol; 2021 Jun; 43(3):409-417. PubMed ID: 33226193
[TBL] [Abstract][Full Text] [Related]
40. Associations of common polymorphisms in the thymidylate synthase, reduced folate carrier and 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase genes with folate and homocysteine levels and venous thrombosis risk.
Gellekink H; Blom HJ; den Heijer M
Clin Chem Lab Med; 2007; 45(4):471-6. PubMed ID: 17439323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
